Compulsory Licensing. If a Third Party seeks a compulsory license for a Collaboration Product in accordance with appropriate provisions of the laws of any country and ISIS and ZENECA agree that the Third Party is legally entitled to such license or the Third * CONFIDENTIAL TREATMENT REQUESTED
Appears in 2 contracts
Sources: Research and Development (Isis Pharmaceuticals Inc), Research and Development Agreement (Isis Pharmaceuticals Inc)